Description
Glofitamab, sold under the brand name Columvi, is a bispecific monoclonal antibody used for the treatment of diffuse large B-cell lymphoma. It is a bispecific CD20-directed CD3 T-cell engager.
It was approved for medical use in Canada in March 2023, in the United States in June 2023, and in the European Union in July 2023.
How and where to buy glofitamab?
Glofitamab-gxbm is a Generic Name for the trade name drug Columvi. Columvi® is approved by the FDA. Date of approval: June 15, 2023. Columvi® is supplied as Injections: 2.5 mg/2.5 mL (1 mg/mL) & 10 mg/10 mL (1 mg/mL) in a single-dose vial for intravenous use/administration.. glofitamab can be ordered on request direct from Medvitaz Pharma Solutions if the drug has not been approved or is not available in your country. We help you to get genuine, affordable and assurance of delivery at Delhi, Gurgaon, Noida, Ghaziabad, Chandigarh, Dehradun, Jaipur, Agra, Vadodara, Surat, Ahmedabad, Mumbai, Pune. Bhopal, Nagpur, Srinagar, Visakhapatnam, Vijayawada, Chennai, Bangalore, Thiruvananthapuram, Kerala, Guwahati, Kolkata, Mumbai. To get best retail price/cost of glofitamab in India, Call 8750295029 or Email [email protected].
We can help facilitate the supply of Columvi® through legal channels.